Dow Down 0.18% Nasdaq Up 0.39%

NPS Pharmaceuticals, Inc. (NPSP)

-NMS
29.42 Down 0.76(2.52%) Sep 2, 4:00PM EDT
Prev Close:30.18
Open:30.18
Bid:29.26 x 400
Ask:N/A
1y Target Est:37.46
Beta:0.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:28.93 - 30.23
52wk Range:21.60 - 39.68
Volume:1,853,410
Avg Vol (3m):1,751,560
Market Cap:3.14B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NPSPDown 2.52%3.14B
ABTDown 0.02%63.50B
BIIBDown 0.10%80.92B

Key Statistics

Forward P/E (1 yr):25.58
P/S (ttm):16.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.03
Quarterly EPS Est (Sep-14) :0.01
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):9.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback